Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 28181 - 28200 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EC02) dabrafenib (adm: O) | Tafinlar 50 mg capsule, 120 | Capsule 50 mg (as mesilate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EC02) dabrafenib (adm: O) | Tafinlar 75 mg capsule, 120 | Capsule 75 mg (as mesilate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EE01) trametinib (adm: O) | Mekinist 500 microgram tablet, 30 | Tablet 500 micrograms, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EE01) trametinib (adm: O) | Mekinist 2 mg tablet, 30 | Tablet 2 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EX27) capivasertib | Truqap 160 mg tablet, 64 | Tablet 160 mg, 64 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaPtyLtd |
| Australia | (L01EX27) capivasertib | Truqap 200 mg tablet, 64 | Tablet 200 mg, 64 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaPtyLtd |
| Australia | (L01XA02) carboplatin | Carboplatin (Accord) 450 mg/45 mL injection, 45 mL vial | Solution for I.V. injection 450 mg in 45 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePty.Ltd. |
| Australia | (L01XA02) carboplatin | Carboplatin (Accord) 450 mg/45 mL injection, 45 mL vial | Solution for I.V. injection 450 mg in 45 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePty.Ltd. |
| Australia | (L01XA03) oxaliplatin | Oxaliplatin (Baxter) 100 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 100 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | BAXTERHEALTHCAREPTYLTD |
| Australia | (L01XA03) oxaliplatin | Oxaliplatin (Baxter) 100 mg/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 100 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | BAXTERHEALTHCAREPTYLTD |
| Australia | (L01XG01) bortezomib | Bortezomib (Accord) 2.5 mg/mL injection, 1 mL vial | Solution for injection 2.5 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | AccordHealthcarePty.Ltd. |
| Australia | (L01XG01) bortezomib | Bortezomib (Accord) 2.5 mg/mL injection, 1 mL vial | Solution for injection 2.5 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | AccordHealthcarePty.Ltd. |
| Australia | (L01XG01) bortezomib | Bortezomib (Ever Pharma) 2.5 mg/mL injection, 1 mL vial | Solution for injection 2.5 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | InterPharmaPtyLtd |
| Australia | (L01XG01) bortezomib | Bortezomib (Ever Pharma) 2.5 mg/mL injection, 1 mL vial | Solution for injection 2.5 mg in 1 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | InterPharmaPtyLtd |
| Australia | (L01XG01) bortezomib | Bortezomib (Ever Pharma) 3.5 mg/1.4 mL injection, 1.4 mL vial | Solution for injection 3.5 mg in 1.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | InterPharmaPtyLtd |
| Australia | (L01XG01) bortezomib | Bortezomib (Ever Pharma) 3.5 mg/1.4 mL injection, 1.4 mL vial | Solution for injection 3.5 mg in 1.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | InterPharmaPtyLtd |
Pages
